PHARMING (ETR:PHARM ) | WebDisclosure

BRIEF

published on 01/21/2026 at 16:18, 28 days ago

Pharming Group NV reçoit une recommandation d'achat avec un objectif de cours relevé

Croissance Des Revenus Part De Marché Notation D'investissement Médicaments Groupe Pharmaceutique NV
BRIEF

published on 01/21/2026 at 16:18, 28 days ago

Pharming Group NV Receives Buy Recommendation with Increased Price Target

Revenue Growth Pharmaceuticals Market Share Investment Rating Pharming Group NV
PRESS RELEASE

published on 01/21/2026 at 16:13, 28 days ago

Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research increases Pharming Group NV's price target to EUR 2.60 with a Buy recommendation, following robust sales growth projections for 2026 and positive revenue figures in 2025

First Berlin Equity Research Sales Growth Price Target Revenue Figures Pharming Group NV
BRIEF

published on 08/20/2025 at 16:42, 5 months 29 days ago

Pharming Group NV affiche de solides performances au deuxième trimestre 2025

Notation D'investissement Pharming Group NV Résultats Du Deuxième Trimestre 2025 Ventes Ruconest Croissance De Joenja
BRIEF

published on 08/20/2025 at 16:42, 5 months 29 days ago

Pharming Group NV Shows Strong Q2/25 Performance

Investment Rating Pharming Group NV Q2 2025 Results Ruconest Sales Joenja Growth
PRESS RELEASE

published on 08/20/2025 at 16:37, 5 months 29 days ago

Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates Pharming Group NV's rating to Buy with a higher target price of EUR 2.40 after strong Q2/25 results, including increased sales for Ruconest and Joenja

First Berlin Equity Research Sales Growth BUY Rating Q2 Results Pharming Group NV
BRIEF

published on 04/03/2025 at 17:13, 10 months 14 days ago

Pharming Group NV: Buy Recommendation Boosted by Optimistic Outlook

Acquisition Clinical Trials Investment Pharming Group Biotech Growth
BRIEF

published on 04/03/2025 at 17:13, 10 months 14 days ago

Pharming Group NV : recommandation d'achat renforcée par des perspectives optimistes

Acquisition Investissement Essais Cliniques Groupe Pharmaceutique Croissance De La Biotechnologie
PRESS RELEASE

published on 04/03/2025 at 17:08, 10 months 14 days ago

Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates Buy recommendation on Pharming Group NV (NL0010391025) to EUR 2.30 target price. Second phase II trial of leniolisib for PIDs announced, acquisition of Abliva completed. Revenue potential >USD1bn

First Berlin Equity Research Leniolisib Pharming Group NV Abliva Acquisition Blockbuster Potential
BRIEF

published on 10/29/2024 at 14:57, 1 year 3 months ago

Pharming Group NV : Perspectives prometteuses malgré le changement de direction

Changement De Direction Croissance Des Ventes Leniolisib Groupe Pharmaceutique Perspectives De Rentabilité

Published on 02/18/2026 at 15:15, 1 hour 40 minutes ago

Host of "The Schaftlein Report" on Patriot.TV Delivers Urgent Warning to Trump: 2026 Midterm Course Correction Needed Now
Published on 02/18/2026 at 15:00, 1 hour 55 minutes ago

Jaguar Health Announces a Special One-time Stock Dividend
Published on 02/18/2026 at 14:25, 2 hours 30 minutes ago

Mako Mining Announces Amended and Restated Definitive Agreements for Restructure of Mt. Hamilton Acquisition Consideration and Filing of Supplement to Management Information Circular
Published on 02/18/2026 at 14:00, 2 hours 55 minutes ago

Revolve Achieves Key Interconnection Milestone On 130 MW "El 24 Wind Project" In Mexico
Published on 02/18/2026 at 14:00, 2 hours 55 minutes ago

Datametrex Receives $1M Order from Fortune 500 Client

View all ACCESSWIRE

Published on 02/18/2026 at 15:50, 1 hour 4 minutes ago

CGTN: Private economy: A key actor in advancing China's economic priorities in 2026 and beyond
Published on 02/18/2026 at 15:48, 1 hour 6 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLC
Published on 02/18/2026 at 15:47, 1 hour 7 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders PLC
Published on 02/18/2026 at 15:46, 1 hour 8 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Ltd
Published on 02/18/2026 at 15:44, 1 hour 10 minutes ago

Form 8.3 - The Vanguard Group, Inc.: NCC Group PLC

View all EQS

Published on 02/18/2026 at 13:45, 3 hours 9 minutes ago

NRJ GROUP - Non renouvellement Licence FM Nationale NRJ Suède
Published on 02/18/2026 at 11:00, 5 hours 54 minutes ago

Mise à disposition des documents préparatoires à l'AG
Published on 02/18/2026 at 08:07, 8 hours 47 minutes ago

TERACT - Changes to Financial calendar
Published on 02/18/2026 at 08:07, 8 hours 47 minutes ago

TERACT - Modification du calendrier financier
Published on 02/18/2026 at 07:30, 9 hours 25 minutes ago

PR Carrefour - Vusion

View all LES ECHOS COMFI WIRE

News